Market Leadership PulseVet is a leading provider of shockwave and regenerative therapies for both equine and companion animals, positioning it strongly in the veterinary medical devices sector with a reputation for innovative and effective treatments.

Recent Acquisitions The company's recent acquisition by Zomedica Pharmaceuticals indicates increased financial stability and expansion potential, making it an attractive partner for distribution channels and veterinary clinics seeking advanced therapeutic solutions.

Product Innovation The launch of a specialized companion-animal device demonstrates PulseVet’s commitment to product innovation, opening opportunities to extend sales to veterinary practices focusing on dogs and cats.

Market Visibility Participation in events such as intercollegiate championships and strategic partnerships like NSBA show PulseVet’s active engagement in the veterinary and equine communities, providing multiple channels for outreach and lead generation.

Financial Scope With revenues under 1 million dollars and a specialized product portfolio, there are significant cross-selling and bundled sales opportunities to grow the footprint within small practices and specialty clinics looking for innovative veterinary therapies.